SRCL - Stericycle Inc Stock Price, Fair Value and News

46.51USD-3.36 (-6.74%)Market Closed

Market Summary

USD46.51-3.36

Market Closed

-6.74%

SRCL Stock Price

View Fullscreen

SRCL RSI Chart

SRCL Valuation

Market Cap

4.6B

Price/Earnings (Trailing)

-237.52

Price/Sales (Trailing)

1.75

EV/EBITDA

33.16

Price/Free Cashflow

3.6K

SRCL Price/Sales (Trailing)

SRCL Profitability

Operating Margin

19.76%

EBT Margin

0.15%

Return on Equity

-0.77%

Return on Assets

-0.36%

Free Cashflow Yield

0.03%

SRCL Fundamentals

SRCL Revenue

Revenue (TTM)

2.6B

Rev. Growth (Yr)

-2.84%

Rev. Growth (Qtr)

1.98%

SRCL Earnings

Earnings (TTM)

-19.5M

Earnings Growth (Yr)

15.93%

Earnings Growth (Qtr)

-11.49%

Breaking Down SRCL Revenue

Last 7 days

-4.8%

Last 30 days

-11.8%

Last 90 days

-5.6%

Trailing 12 Months

10.1%

How does SRCL drawdown profile look like?

SRCL Financial Health

Current Ratio

1.11

Debt/Equity

0.55

Debt/Cashflow

0.1

SRCL Investor Care

Shares Dilution (1Y)

0.43%

Diluted EPS (TTM)

-0.22

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	2.6B	0	0	0
2023	2.7B	2.7B	2.7B	2.7B
2022	2.6B	2.7B	2.7B	2.7B
2021	2.6B	2.6B	2.6B	2.6B
2020	3.3B	3.0B	2.8B	2.7B
2019	3.4B	3.4B	3.4B	3.3B
2018	3.6B	3.5B	3.5B	3.5B
2017	3.6B	3.6B	3.6B	3.6B
2016	3.2B	3.4B	3.5B	3.6B
2015	2.6B	2.7B	2.8B	3.0B
2014	2.2B	2.3B	2.4B	2.6B
2013	2.0B	2.0B	2.1B	2.1B
2012	1.7B	1.8B	1.9B	1.9B
2011	1.5B	1.6B	1.6B	1.7B
2010	1.2B	1.3B	1.4B	1.4B
2009	1.1B	1.1B	1.2B	1.2B
2008	0	0	0	1.1B

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Stericycle Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 15, 2024	culotta dominic	sold (taxes)	-65,584	52.3	-1,254	evp engineering
Mar 15, 2024	miller cindy j	acquired	-	-	27,095	chief executive officer
Mar 15, 2024	reuter joseph anthony	acquired	-	-	5,062	evp & chief people officer
Mar 15, 2024	moore richard michael	acquired	-	-	5,146	evp north america operations
Mar 15, 2024	reuter joseph anthony	sold (taxes)	-77,613	52.3	-1,484	evp & chief people officer
Mar 15, 2024	hoffman richard j	acquired	-	-	2,832	svp & chief accounting officer
Mar 15, 2024	hoffman richard j	sold (taxes)	-43,199	52.3	-826	svp & chief accounting officer
Mar 15, 2024	moore richard michael	sold (taxes)	-78,920	52.3	-1,509	evp north america operations
Mar 15, 2024	culotta dominic	acquired	-	-	5,146	evp engineering
Mar 15, 2024	weisman michael	sold (taxes)	-57,425	52.3	-1,098	evp corp ethics and compliance

Which funds bought or sold SRCL recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 24, 2024	Robeco Institutional Asset Management B.V.	sold off	-100	-155,817	-	-%
Apr 24, 2024	BROWN ADVISORY INC	reduced	-49.28	-259,520	304,472	-%
Apr 24, 2024	BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC	unchanged	-	99.00	1,635	-%
Apr 24, 2024	RAYMOND JAMES TRUST N.A.	reduced	-12.71	-96,481	1,264,640	0.03%
Apr 24, 2024	Newbridge Financial Services Group, Inc.	unchanged	-	430	7,121	-%
Apr 24, 2024	Catalyst Capital Advisors LLC	reduced	-5.26	173	20,889	-%
Apr 24, 2024	DekaBank Deutsche Girozentrale	sold off	-100	-394,000	-	-%
Apr 23, 2024	Louisiana State Employees Retirement System	added	2.31	114,590	1,403,150	0.03%
Apr 23, 2024	WASHINGTON TRUST Co	added	11.58	3,534	22,367	-%
Apr 23, 2024	FIFTH THIRD BANCORP	added	2.09	218,255	2,737,090	0.01%

Are Funds Buying or Selling SRCL?

Are funds buying SRCL calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own SRCL

No. of Funds

Unveiling Stericycle Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	alliancebernstein l.p.	8.6%	7,917,576	SC 13G/A
Feb 13, 2024	black creek investment management inc.	5.96%	0	SC 13G
Feb 13, 2024	vanguard group inc	9.69%	8,969,118	SC 13G/A
Feb 12, 2024	clarkston capital partners, llc	6.99%	6,471,301	SC 13G/A
Feb 09, 2024	capital research global investors	6.5%	5,987,937	SC 13G
Jan 25, 2024	blackrock inc.	8.3%	7,690,546	SC 13G/A
Feb 14, 2023	price t rowe associates inc /md/	4.9%	4,542,380	SC 13G/A
Feb 14, 2023	clarkston capital partners, llc	6.87%	6,332,330	SC 13G
Feb 14, 2023	alliancebernstein l.p.	7.6%	6,963,391	SC 13G/A
Feb 09, 2023	vanguard group inc	9.60%	8,845,201	SC 13G/A

Recent SEC filings of Stericycle Inc

View All Filings

Date Filed	Form Type	Document
Apr 25, 2024	10-Q	Quarterly Report
Apr 25, 2024	8-K	Current Report
Apr 05, 2024	ARS	ARS
Apr 05, 2024	DEF 14A	DEF 14A
Apr 05, 2024	DEFA14A	DEFA14A
Mar 19, 2024	4	Insider Trading
Mar 19, 2024	4	Insider Trading
Mar 19, 2024	4	Insider Trading
Mar 19, 2024	4	Insider Trading
Mar 19, 2024	4	Insider Trading

Peers (Alternatives to Stericycle Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ADP	101.2B	18.6B	0.54%	16.87%	28.45	5.45	7.76%	13.08%
CTAS	67.5B	9.4B	4.99%	51.27%	44.88	7.17	9.34%	15.98%
CPRT	53.1B	4.1B	-3.43%	43.35%	39.17	13.09	10.52%	25.37%
EFX	28.0B	5.4B	-13.11%	13.93%	50.15	5.23	5.76%	-4.95%
BAH	18.9B	10.3B	-1.11%	54.68%	46.13	1.83	13.90%	-5.05%
ALLE	10.9B	3.6B	-6.38%	16.13%	20.25	3.02	4.33%	10.65%
MID-CAP
RHI	7.4B	6.4B	-8.82%	-0.04%	18.07	1.16	-11.68%	-37.51%
AL	5.7B	2.7B	2.50%	33.81%	9.32	2.13	15.87%	733.47%
SRCL	4.6B	2.6B	-11.83%	10.13%	-237.52	1.75	-3.11%	-123.81%
ABM	2.8B	8.2B	1.37%	8.46%	10.9	0.34	3.98%	33.49%
SMALL-CAP
AZZ	1.9B	2.7B	-4.31%	99.08%	21.53	0.69	104.63%	175.67%
ALTG	375.6M	1.9B	-10.76%	-16.91%	42.2	0.2	19.40%	-4.30%
ARC	117.2M	281.2M	-0.36%	-8.97%	14.23	0.42	-1.68%	-25.77%
AQMS	56.0M	1.1M	-5.66%	-56.14%	-2.34	49.78	336.95%	-55.13%
AWX	8.6M	80.5M	-2.22%	-18.12%	-4.77	0.11	-0.82%	-207.00%

Stericycle Inc News

Latest updates

Stericycle Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	2.0%	665	652	654	670	684	670	690	680	664	657	649	673	668	656	636	598	785	800	833	846	830
Gross Profit	-0.7%	255	257	246	251	261	254	266	261	245	247	240	269	261	270	267	230	287	280	295	303	297
S&GA Expenses	-1.7%	216	220	217	221	216	211	216	222	239	251	279	214	202	219	219	201	259	246	247	277	286
EBITDA Margin	2.4%	0.07*	0.07*	0.08*	0.09*	0.11*	0.10*	0.08*	0.04*	0.05*	0.06*	0.09*	0.09*	-	-	-	-	-	-	-	-	-
Interest Expenses	1070.0%	35.00	3.00	29.00	5.00	33.00	8.00	32.00	4.00	28.00	2.00	32.00	3.00	20.00	6.00	24.00	10.00	36.00	32.00	21.00	27.00	22.00
Income Taxes	34.5%	7.00	6.00	5.00	6.00	9.00	6.00	5.00	8.00	3.00	8.00	-3.00	9.00	14.00	23.00	7.00	9.00	-38.40	-8.80	-8.60	-3.00	4.00
Earnings Before Taxes	1.0%	21.00	20.00	7.00	-43.70	20.00	38.00	33.00	19.00	-11.20	-8.80	-68.90	38.00	40.00	72.00	-74.40	5.00	-58.30	-228	-67.60	-33.20	-34.00
EBT Margin	22.1%	0.00*	0.00*	0.01*	0.02*	0.04*	0.03*	0.01*	-0.03*	-0.02*	0.00*	0.03*	0.03*	-	-	-	-	-	-	-	-	-
Net Income	-11.5%	13.00	15.00	2.00	-49.50	11.00	32.00	28.00	11.00	-14.10	-16.40	-65.90	29.00	26.00	49.00	-80.90	-4.10	-19.90	-219	-59.20	-30.50	-37.80
Net Income Margin	7.8%	-0.01*	-0.01*	0.00*	0.01*	0.03*	0.02*	0.00*	-0.03*	-0.03*	-0.01*	0.01*	0.01*	-	-	-	-	-	-	-	-	-
Free Cashflow	-567.0%	-97.60	21.00	-0.10	78.00	13.00	131	26.00	-12.10	-76.30	70.00	26.00	52.00	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	1.6%	5,436	5,353	5,246	5,213	5,332	5,334	5,341	5,408	5,477	5,473	5,470	5,517	5,531	5,582	5,633	5,685	6,353	6,437	6,676	6,870	6,851
Current Assets	8.5%	729	672	587	527	564	559	598	597	614	576	570	548	537	553	566	593	1,203	707	751	819	802
Cash Equivalents	-12.2%	31.00	35.00	30.00	31.00	60.00	56.00	44.00	46.00	60.00	56.00	38.00	62.00	50.00	53.00	59.00	42.00	36.00	35.00	31.00	35.00	48.00
Net PPE	-	-	-	703	693	713	716	712	720	713	711	704	713	702	701	696	706	728	799	786	786	760
Goodwill	0.1%	2,758	2,756	2,739	2,752	2,788	2,785	2,749	24.00	2,809	2,816	2,799	2,814	2,811	2,819	2,802	2,786	2,782	2,982	3,178	3,195	3,198
Liabilities	2.9%	2,913	2,830	2,770	2,730	2,886	2,910	3,015	3,054	3,096	3,070	3,047	3,024	3,083	3,148	3,295	3,389	4,073	4,102	4,199	4,308	4,280
Current Liabilities	-8.8%	655	718	650	619	581	622	587	619	670	732	687	677	674	697	687	660	819	757	796	784	786
Long Term Debt	9.5%	1,399	1,278	1,297	1,294	1,487	1,484	1,652	1,676	1,678	1,590	1,621	1,605	1,651	1,689	1,879	1,999	2,519	2,559	2,617	2,697	2,702
Shareholder's Equity	0.0%	2,523	2,523	2,476	2,483	2,446	2,420	2,326	2,354	2,381	2,403	2,422	2,494	2,449	2,434	2,339	2,296	2,280	2,335	2,477	2,562	2,571
Retained Earnings	0.9%	1,403	1,389	1,375	1,373	1,422	1,411	1,379	1,351	1,341	1,355	1,372	1,438	1,409	1,383	1,334	1,415	1,420	1,442	1,662	1,721	1,751
Additional Paid-In Capital	-0.1%	1,315	1,317	1,312	1,300	1,289	1,285	1,281	1,271	1,263	1,262	1,254	1,245	1,236	1,234	1,228	1,222	1,213	1,206	1,197	1,193	1,171
Accumulated Depreciation	-	-	-	665	662	677	658	664	681	678	659	669	662	642	630	662	642	629	668	754	738	710
Shares Outstanding	0.7%	93.00	92.00	93.00	93.00	92.00	92.00	92.00	92.00	92.00	92.00	92.00	92.00	-	-	-	-	-	-	-	-	-
Minority Interest	0%	0.00	0.00	1.00	1.00	1.00	4.00	3.00	4.00	4.00	4.00	4.00	4.00	4.00	4.00	5.00	5.00	4.00	4.00	4.00	4.00	4.00
Float	-	-	-	-	4,267	-	-	-	4,012	-	-	-	6,569	-	-	-	5,121	-	-	-	4,351	-

Cashflow (Last 12 Months)

(In Thousands)

Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-209.0%	-54,500	50,000	38,400	105,400	49,500	157,100	61,500	20,400	-38,800	100,900	52,400	87,200	62,600	165,000	157,900	125,200	82,100	46,800	130,200	34,800	36,200
Share Based Compensation	-48.1%	2,700	5,200	10,400	10,900	6,900	5,000	7,500	7,800	4,800	8,300	6,600	7,100	5,100	5,200	7,400	7,800	5,100	3,400	3,700	5,700	4,300
Cashflow From Investing	-100.7%	-56,800	-28,300	-41,900	60,900	-34,500	18,900	-35,900	-30,800	-36,800	-17,100	-14,600	-33,900	-24,500	53,200	-24,100	392,400	-40,100	37,300	-48,200	-40,800	-52,300
Cashflow From Financing	819.1%	109,300	-15,200	2,700	-196,300	-11,600	-167,700	-22,300	-400	79,400	-64,700	-60,600	-42,500	-40,100	-224,200	-117,300	-511,400	-39,600	-81,600	-83,300	-8,000	31,300

SRCL Income Statement

2023-12-31

CONSOLIDATED STATEMENTS OF (LOSS) INCOME - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Revenues	$ 2,659.3	$ 2,704.7	$ 2,646.9
Cost of revenues	1,644.7	1,679.1	1,629.7
Gross profit	1,014.6	1,025.6	1,017.2
Selling, general and administrative expenses	873.9	887.5	946.6
Divestiture losses (gains), net	63.4	(15.6)	(1.7)
Income from operations	77.3	153.7	72.3
Interest expense, net	(73.9)	(75.5)	(71.9)
Other (expense) income, net	(0.1)	0.7	0.3
Income before income taxes	3.3	78.9	0.7
Income tax expense	(24.6)	(22.4)	(27.5)
Net (loss) income	(21.3)	56.5	(26.8)
Net income attributable to noncontrolling interests	(0.1)	(0.5)	(1.0)
Net (loss) income attributable to Stericycle, Inc. common shareholders	$ (21.4)	$ 56.0	$ (27.8)
(Loss) earnings per common share attributable to Stericycle, Inc. common shareholders:
Basic (in dollars per share)	$ (0.23)	$ 0.61	$ (0.30)
Diluted (in dollars per share)	$ (0.23)	$ 0.61	$ (0.30)
Weighted average number of common shares Outstanding:
Basic (in shares)	92.4	92.1	91.8
Diluted (in shares)	92.4	92.4	91.8

SRCL Balance Sheet

2023-12-31

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Current Assets:
Cash and cash equivalents	$ 35.3	$ 56.0
Accounts receivable, less allowance for doubtful accounts of $44.7 in 2023 and $53.3 in 2022	553.9	414.5
Prepaid expenses	31.6	33.2
Other current assets	50.7	55.0
Total Current Assets	671.5	558.7
Property, plant and equipment, less accumulated depreciation of $675.4 in 2023 and $657.7 in 2022	708.3	715.7
Operating lease right-of-use assets	464.3	398.9
Goodwill	2,755.6	2,784.9
Intangible assets, less accumulated amortization of $925.8 in 2023 and $823.3 in 2022	686.5	811.1
Other assets	66.4	64.8
Total Assets	5,352.6	5,334.1
Current Liabilities:
Current portion of long-term debt	19.6	22.3
Bank overdraft	1.0	2.9
Accounts payable	212.1	213.5
Accrued liabilities	259.5	244.1
Operating lease liabilities	105.4	91.2
Deferred revenues	72.6	7.9
Other current liabilities	47.8	40.0
Total Current Liabilities	718.0	621.9
Long-term debt, net	1,277.8	1,484.0
Long-term operating lease liabilities	378.9	329.0
Deferred income taxes	420.5	427.0
Long-term tax payable	6.4	11.8
Other liabilities	28.1	35.9
Total Liabilities	2,829.7	2,909.6
Commitments and contingencies
EQUITY
Preferred stock (par value $0.01 per share, 1.0 shares authorized), mandatory convertible preferred stock, Series A, none issued and outstanding in 2023 and 2022	0.0	0.0
Common stock (par value $0.01 per share, 120.0 shares authorized, 92.6 and 92.2 issued and outstanding in 2023 and 2022, respectively)	0.9	0.9
Additional paid-in capital	1,316.7	1,285.4
Retained earnings	1,389.4	1,410.8
Accumulated other comprehensive loss	(184.5)	(276.9)
Total Stericycle, Inc.’s Equity	2,522.5	2,420.2
Noncontrolling interests	0.4	4.3
Total Equity	2,522.9	2,424.5
Total Liabilities and Equity	$ 5,352.6	$ 5,334.1

About Stericycle Inc

Stericycle, Inc., together with its subsidiaries, provides regulated and compliance solutions in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, controlled substance waste disposal, healthcare hazardous waste, and COVID 19 waste disposal; specialty services, such as MedDrop medication collection kiosks, safe community solutions, sharps mailback solutions, and maritime waste services; medical supply store services; pharmaceutical waste services; hazardous waste disposal; compliance programs under the Steri-Safe, Clinical Services, First Practice Management, SeguriMed, and EnviroAssure brand names. It also provides secure information destruction services, including document and hard drive destruction services under the Shred-it brand. The company serves healthcare businesses, including hospitals, health systems, physician and dental clinics, surgery centers, veterinary clinics, nursing and long-term care facilities, dialysis centers, pharmacy, lab, research centers, and home health organizations etc.; retailers and manufacturers; and airports and seaports, education institutions, funeral homes and crematories, government and military, banks and professional services, and other businesses. Stericycle, Inc. was incorporated in 1989 and is headquartered in Bannockburn, Illinois.

CEO	Ms. Cindy J. Miller
WEBSITE	stericycle.com
INDUSTRY	Information Technology Services
EMPLOYEES	14550

Stericycle Inc Frequently Asked Questions

What is the ticker symbol for Stericycle Inc? What does SRCL stand for in stocks?

SRCL is the stock ticker symbol of Stericycle Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Stericycle Inc (SRCL)?

As of Thu Apr 25 2024, market cap of Stericycle Inc is 4.31 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of SRCL stock?

You can check SRCL's fair value in chart for subscribers.

What is the fair value of SRCL stock?

You can check SRCL's fair value in chart for subscribers. The fair value of Stericycle Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Stericycle Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for SRCL so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Stericycle Inc a good stock to buy?

The fair value guage provides a quick view whether SRCL is over valued or under valued. Whether Stericycle Inc is cheap or expensive depends on the assumptions which impact Stericycle Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for SRCL.

What is Stericycle Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Apr 25 2024, SRCL's PE ratio (Price to Earnings) is -202.13 and Price to Sales (PS) ratio is 1.62. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. SRCL PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Stericycle Inc's stock?

In the past 10 years, Stericycle Inc has provided -0.087 (multiply by 100 for percentage) rate of return.